These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 22801386)

  • 1. Identification of people with heterozygous familial hypercholesterolemia.
    Haase A; Goldberg AC
    Curr Opin Lipidol; 2012 Aug; 23(4):282-9. PubMed ID: 22801386
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The molecular genetic basis and diagnosis of familial hypercholesterolemia in Denmark.
    Jensen HK
    Dan Med Bull; 2002 Nov; 49(4):318-45. PubMed ID: 12553167
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Importance of early recognition of heterozygous familial hypercholesterolaemia.
    Ryan A; Byrne CD
    Curr Opin Lipidol; 2015 Aug; 26(4):298-303. PubMed ID: 26103611
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Heterozygous familial hypercholesterolemia].
    Özcan ÖU; Güleç S
    Turk Kardiyol Dern Ars; 2014 Oct; 42 Suppl 2():10-8. PubMed ID: 25693359
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Screening methods in the diagnosis and assessment of children and adolescents with familial hypercholesterolemia.
    Langslet G; Ose L
    Expert Rev Cardiovasc Ther; 2013 Aug; 11(8):1061-6. PubMed ID: 23984929
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The detection of heterozygous familial hypercholesterolemia in Ireland.
    O'Kane MJ; Menown IB; Graham I; Maher V; Tomkin G; Nicholls P; Graham C
    Adv Ther; 2012 May; 29(5):456-63. PubMed ID: 22610724
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Familial hypercholesterolemia in children and adolescents.
    McCrindle BW
    Curr Opin Lipidol; 2012 Dec; 23(6):525-31. PubMed ID: 22914663
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patients' attitudes toward detection of heterozygous familial hypercholesterolemia.
    Andersen LK; Jensen HK; Juul S; Faergeman O
    Arch Intern Med; 1997 Mar; 157(5):553-60. PubMed ID: 9066460
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rationale and design of the familial hypercholesterolemia foundation CAscade SCreening for Awareness and DEtection of Familial Hypercholesterolemia registry.
    O'Brien EC; Roe MT; Fraulo ES; Peterson ED; Ballantyne CM; Genest J; Gidding SS; Hammond E; Hemphill LC; Hudgins LC; Kindt I; Moriarty PM; Ross J; Underberg JA; Watson K; Pickhardt D; Rader DJ; Wilemon K; Knowles JW
    Am Heart J; 2014 Mar; 167(3):342-349.e17. PubMed ID: 24576518
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost-effectiveness analysis of alternative screening and treatment strategies for heterozygous familial hypercholesterolemia in the United States.
    Chen CX; Hay JW
    Int J Cardiol; 2015 Feb; 181():417-24. PubMed ID: 25569270
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of registries and genetic databases in familial hypercholesterolemia.
    Kindt I; Mata P; Knowles JW
    Curr Opin Lipidol; 2017 Apr; 28(2):152-160. PubMed ID: 28169870
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advanced method for the identification of patients with inherited hypercholesterolemia.
    Defesche JC; Lansberg PJ; Umans-Eckenhausen MA; Kastelein JJ
    Semin Vasc Med; 2004 Feb; 4(1):59-65. PubMed ID: 15199434
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of familial heterozygous hypercholesterolemia: Position Paper of the Polish Lipid Expert Forum.
    Rynkiewicz A; Cybulska B; Banach M; Filipiak K; Guzik T; Idzior-Waluś B; Imiela J; Jankowski P; Kłosiewicz-Latoszek L; Limon J; Myśliwiec M; Opolski G; Steciwko A; Stępińska J; Zdrojewski T
    J Clin Lipidol; 2013; 7(3):217-21. PubMed ID: 23725921
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Defining the challenges of FH screening for familial hypercholesterolemia.
    Defesche JC
    J Clin Lipidol; 2010; 4(5):338-41. PubMed ID: 21122674
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cascade genetic screening for familial hypercholesterolemia.
    Leren TP
    Clin Genet; 2004 Dec; 66(6):483-7. PubMed ID: 15521974
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost-effectiveness analysis of the genetic screening program for familial hypercholesterolemia in The Netherlands.
    Wonderling D; Umans-Eckenhausen MA; Marks D; Defesche JC; Kastelein JJ; Thorogood M
    Semin Vasc Med; 2004 Feb; 4(1):97-104. PubMed ID: 15199439
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Integrating provision of specialist lipid services with cascade testing for familial hypercholesterolaemia.
    Datta BN; McDowell IF; Rees A
    Curr Opin Lipidol; 2010 Aug; 21(4):366-71. PubMed ID: 20613514
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Chinese homozygote of familial hypercholesterolemia: identification of a novel C263R mutation in the LDL receptor gene.
    Wang D; Wu B; Li Y; Heng W; Zhong H; Mu Y; Wang J
    J Hum Genet; 2001; 46(3):152-4. PubMed ID: 11310584
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnosis and Treatment of Heterozygous Familial Hypercholesterolemia.
    McGowan MP; Hosseini Dehkordi SH; Moriarty PM; Duell PB
    J Am Heart Assoc; 2019 Dec; 8(24):e013225. PubMed ID: 31838973
    [No Abstract]   [Full Text] [Related]  

  • 20. Familial hypercholesterolemia: current treatment and advances in management.
    Huijgen R; Vissers MN; Defesche JC; Lansberg PJ; Kastelein JJ; Hutten BA
    Expert Rev Cardiovasc Ther; 2008 Apr; 6(4):567-81. PubMed ID: 18402545
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.